SBC Medical Group's 8-K Filing: Key Insights for Investors

Here are the key insights extracted from the provided section of the financial report:
- Entity Identification:
- Company Name: SBC Medical Group Holdings Incorporated
- CIK: 0001930313
- SEC File Number: 001-41462
- EIN: 88-1192288
- Address: 200 Spectrum Center Dr. STE 300, Irvine, CA 92618
- Phone: 949-593-0250
- Report Type:
- The document is identified as an 8-K filing, indicating it is a current report that companies must file with the SEC to announce major events that shareholders should know about.
- Date of Filing:
- Filing Date: December 20, 2024
- Stock Information:
- Common Stock:
- Par Value: $0.0001 per share.
- Ticker symbol: SBC, traded on NASDAQ.
- Redeemable Warrants:
- Each whole warrant is exercisable for one share of Common Stock at an exercise price of $11.50 per share.
- Ticker symbol: SBCWW, traded on NASDAQ.
- Contextual Information:
- The report references specific periods and contexts, indicating that the details provided pertain to the status as of December 20, 2024.
- Units of Measurement:
- The report uses various units, including USD for monetary values and shares for stock quantities.
- Segment Information:
- The report includes classifications for both common stock and redeemable warrants under specific dimensions, indicating a structured reporting approach that adheres to US GAAP.
Summary:
The filing provides essential details about SBC Medical Group Holdings, including its stock and warrant offerings, which are relevant for investors assessing the company's financial standing and potential investment opportunities. The exercise price for warrants and the par value of stock shares are crucial for evaluating the company's equity structure and investor rights.